Other manifestations are Castleman’s disease, sclerotic bone lesions, organomegaly, extravascular volume overload, increased cerebrospinal fluid protein, endocrinopathy, skin changes, papilledema, thrombocytosis, polycythemia, thromboembolic disease, and elevated VEGF levels. Here, VEGFA is linked to Thrombocytosis.